Position in NKTR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,706,016
+$6,231,363 QoQ
Shares Held
96,061
+1356.1% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 239 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. NKTR ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in NKTR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,706,016 | 96,061 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $474,653 | 6,597 | Shares | Defined | 2026-05-05 | |
| 2025-09-30 | $246,205 | 4,327 | Shares | Defined | 2025-11-03 | |
| 2025-03-31 | $267,438 | 393,293 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $381,592 | 410,316 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $533,410 | 410,316 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $683,902 | 551,535 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $17,550 | 18,872 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $47,823 | 85,400 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $52,955 | 88,259 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $73,192 | 126,197 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,117,345 | 1,596,210 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,686,950 | 1,631,395 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,502,327 | 1,719,478 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,418,818 | 1,689,163 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $9,652,097 | 1,790,742 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $23,003,474 | 1,702,700 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $30,862,192 | 1,718,385 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $29,664,525 | 1,728,702 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $34,441,160 | 1,722,058 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $29,462,241 | 1,733,073 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $29,732,627 | 1,792,202 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $43,029,516 | 1,857,924 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $32,138,332 | 1,800,467 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||